Cytokinetics Inc
NASDAQ:CYTK

Watchlist Manager
Cytokinetics Inc Logo
Cytokinetics Inc
NASDAQ:CYTK
Watchlist
Price: 31.06 USD -0.8%
Market Cap: 3.7B USD

Intrinsic Value

CYTK's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one CYTK stock under the Base Case scenario is 32.56 USD. Compared to the current market price of 31.06 USD, Cytokinetics Inc is Undervalued by 5%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CYTK Intrinsic Value
32.56 USD
Undervaluation 5%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Cytokinetics Inc

Valuation History Unavailable

Historical valuation for CYTK cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Cytokinetics Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cytokinetics Inc

Current Assets 956.1m
Cash & Short-Term Investments 938.2m
Receivables 2m
Other Current Assets 15.8m
Non-Current Assets 308m
Long-Term Investments 150.7m
PP&E 144.6m
Other Non-Current Assets 12.7m
Efficiency

Free Cash Flow Analysis
Cytokinetics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cytokinetics Inc

Revenue
19.2m USD
Operating Expenses
-584.9m USD
Operating Income
-565.6m USD
Other Expenses
-49.6m USD
Net Income
-615.3m USD
Fundamental Scores

CYTK Profitability Score
Profitability Due Diligence

Cytokinetics Inc's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional 3-Year Average ROIC
Exceptional Revenue Growth Forecast
Exceptional ROE
64/100
Profitability
Score

Cytokinetics Inc's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

CYTK Solvency Score
Solvency Due Diligence

Cytokinetics Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Negative Net Debt
Long-Term Solvency
43/100
Solvency
Score

Cytokinetics Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CYTK Price Targets Summary
Cytokinetics Inc

Wall Street analysts forecast CYTK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CYTK is 78.54 USD with a low forecast of 41.41 USD and a high forecast of 126 USD.

Lowest
Price Target
41.41 USD
33% Upside
Average
Price Target
78.54 USD
153% Upside
Highest
Price Target
126 USD
306% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Cytokinetics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CYTK is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

CYTK Insider Trading
Buy and sell transactions by insiders

CYTK News

Other Videos
What is the Intrinsic Value of one CYTK stock?

The intrinsic value of one CYTK stock under the Base Case scenario is 32.56 USD.

Is CYTK stock undervalued or overvalued?

Compared to the current market price of 31.06 USD, Cytokinetics Inc is Undervalued by 5%.

Back to Top